MOLECULAR EVIDENCE DEVELOPMENT CONSORTIUM (EIN 472986038) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

DANE J DICKSON MD

Phone

2083563677

Tax Period

2018-01-01 to 2018-12-31

MOLECULAR EVIDENCE DEVELOPMENT CONSORTIUM, founded in 2015, is a small nonprofit that reported $343K in total revenue in fiscal year 2018. Revenue fell 60% from the prior year — a significant decline worth monitoring. Expenses of $865K exceeded revenue, resulting in a 152% operating deficit.

Mission

MED-C WAS A NONPROFIT ORGANIZATION CREATED TO HELP MAKE PERSONALIZED MEDICINE A REALITY. MED-C WAS BRINGING TOGETHER EACH OF HEALTH CARE'S KEY GROUPS - PATIENT, PHYSICIANS, PAYORS, LABS, PHARMA AND REGULATORS TO HELP UNLOCK THE TREMENDOUS POTENTIAL OF PERSONALIZED MEDICINE. TO ACHIEVE THIS GOAL, MED-C HAD LAUNCHED A VAST DATABASE THAT GATHERED GENOMIC-LEVEL DATA ON CANCER PATIENTS AND THOROUGH INFORMATION ABOUT THEIR TREATMENTS AND CLINICAL OUTCOMES.UNFORTUNATELY DUE TO UNFORESEEABLE REGULATORY CIRCUMSTANCES MED-C HAD TO DISCONTINUE IT'S OPERATIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $251,072

Program Service Revenue $699,291

Investment Income $-607,064

Other Revenue $0

TOTAL REVENUE $343,299

Expense Breakdown

Grants Paid $0

Salaries & Benefits $241,043

Fundraising Expenses $0

Program Expenses $695,008

Other Expenses $624,363

TOTAL EXPENSES $865,406

Year-over-Year Comparison

	2018	2017	Change
Revenue	$343,299	$855,663	-0.6%
Expenses	$865,406	$1,265,873	-0.3%
Net Income	$-522,107	$-410,210	+0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$274,335

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JEFF ALLEN PHD	Chairman	3.00	Director	$0	$0	$0
RON COLLETTE CISSP	BOARD MEMBER	1.00	Director	$0	$0	$0
MARC SAMUELS JD	BOARD MEMBER	1.00	Director	$0	$0	$0
DANE J DICKSON MD	CEO	40.00	Officer	$157,154	$0	$157,154
REBECCA OWENS	COO	40.00	Officer	$117,181	$0	$117,181

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2018	$343,299	$865,406	No data	$-522,107

MOLECULAR EVIDENCE DEVELOPMENT CONSORTIUM